The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
The association between clinician-based common terminology criteria for adverse events (CTCAE) and patient-reported outcomes (PRO): a systematic review
Open accessAbstract
PurposeSymptomatic adverse events (AEs) are monitored by clinicians as part of all US-based clinical trials in cancer via the U.S. National Cancer Institute’s Common Terminology Criteria for Adverse Events (CTCAE) for the purposes of ensuring patient safety. Recently, there has been a charge toward capturing the patient perspective for those AEs amenable to patient self-reporting via patient-reported outcomes (PRO). The aim of this review was to summarize the empirically reported association between analogous CTCAE and PRO ratings.MethodsA systematic literature search was conducted using PubMed, EMBASE, Web of Science, and Cochrane databases through July 2015. From a total of 5658 articles retrieved, 28 studies met the inclusion criteria.ResultsAcross studies, patients were of mixed cancer types, including anal, breast, cervical, chronic myeloid leukemia, endometrial, hematological, lung, ovarian, pelvic, pharyngeal, prostate, and rectal. Given this mixture, the AEs captured were variable, with many common across studies (e.g., dyspnea, fatigue, nausea, neuropathy, pain, vomiting), as well as several that were disease-specific (e.g., erectile dysfunction, hemoptysis). Overall, the quantified association between CTCAE and PRO ratings fell in the fair to moderate range and had a large variation across the majority of studies (n = 21).ConclusionsThe range of measures used and symptoms captured varied greatly across the reviewed studies. Regardless of concordance metric employed, reported agreement between CTCAE and PRO ratings was moderate at best. To assist with reconciliation and interpretation of these differences toward ultimately improving patient care, an important next step is to explore approaches to integrate PROs with clinician reporting of AEs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Downs, S. H., & Black, N. (1998) · Journal of Epidemiology and Community Health · doi:10.1136/jech.52.6.377 · Cited by 8,252
Cella, D., Riley, W., Stone, A., Rothrock, N., Reeve, B., Yount, S., Amtmann, D., Bode, R., Buysse, D., Choi, S., et al. (2010) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.04.011 · Cited by 5,128
U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research, & U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health (2006) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-4-79 · Cited by 2,856
Basch, E., Reeve, B. B., Mitchell, S. A., Clauser, S. B., Minasian, L. M., Dueck, A. C., Mendoza, T. R., Hay, J., Atkinson, T. M., Abernethy, A. P., et al. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju244 · Cited by 1,151
Self-citationDueck, A. C., Mendoza, T. R., Mitchell, S. A., Reeve, B. B., Castro, K. M., Rogak, L. J., Atkinson, T. M., Bennett, A. V., Denicoff, A. M., O'Mara, A. M., et al. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.2639 · Cited by 1,030
Self-citationBasch, E., Iasonos, A., McDonough, T., Barz, A., Culkin, A., Kris, M. G., Scher, H. I., & Schrag, D. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70910-x · Cited by 653
Self-citationThe Missing Voice of Patients in Drug-Safety Reporting
Basch, E. (2010) · New England Journal of Medicine · doi:10.1056/nejmp0911494 · Cited by 646
Self-citationThe Prognostic Significance of Patient-Reported Outcomes in Cancer Clinical Trials
Gotay, C. C., Kawamoto, C. T., Bottomley, A., & Efficace, F. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.3439 · Cited by 644
Adverse Symptom Event Reporting by Patients vs Clinicians: Relationships With Clinical Outcomes
Basch, E., Jia, X., Heller, G., Barz, A., Sit, L., Fruscione, M., Appawu, M., Iasonos, A., Atkinson, T., Goldfarb, S., et al. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp386 · Cited by 624
Self-citationFromme, E. K., Eilers, K. M., Mori, M., Hsieh, Y.-C., & Beer, T. M. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.03.025 · Cited by 555
Di Maio, M., Gallo, C., Leighl, N. B., Piccirillo, M. C., Daniele, G., Nuzzo, F., Gridelli, C., Gebbia, V., Ciardiello, F., De Placido, S., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.9334 · Cited by 497
Patient-Reported Outcomes and the Evolution of Adverse Event Reporting in Oncology
Trotti, A., Colevas, A. D., Setser, A., & Basch, E. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.4784 · Cited by 329
Self-citationReliability of adverse symptom event reporting by clinicians
Atkinson, T. M., Li, Y., Coffey, C. W., Sit, L., Shaw, M., Lavene, D., Bennett, A. V., Fruscione, M., Rogak, L., Hay, J., et al. (2012) · Quality of Life Research · doi:10.1007/s11136-011-0031-4 · Cited by 231
Self-citationPatient Self-Reports of Symptoms and Clinician Ratings as Predictors of Overall Cancer Survival
Quinten, C., Maringwa, J., Gotay, C. C., Martinelli, F., Coens, C., Reeve, B. B., Flechtner, H., Greimel, E., King, M., Osoba, D., et al. (2011) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djr485 · Cited by 226
Shimozuma, K., Ohashi, Y., Takeuchi, A., Aranishi, T., Morita, S., Kuroi, K., Ohsumi, S., Makino, H., Mukai, H., Katsumata, N., et al. (2009) · Supportive Care in Cancer · doi:10.1007/s00520-009-0613-7 · Cited by 193
Alberti, P., Rossi, E., Cornblath, D. R., Merkies, I. S. J., Postma, T. J., Frigeni, B., Bruna, J., Velasco, R., Argyriou, A. A., Kalofonos, H. P., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdt409 · Cited by 179
the NCI PRO-CTCAE Study Group, Hay, J. L., Atkinson, T. M., Reeve, B. B., Mitchell, S. A., Mendoza, T. R., Willis, G., Minasian, L. M., Clauser, S. B., Denicoff, A., et al. (2014) · Quality of Life Research · doi:10.1007/s11136-013-0470-1 · Cited by 165
Self-citationBasch, E. (2013) · Annual Review of Medicine · doi:10.1146/annurev-med-010713-141500 · Cited by 139
Self-citationCirillo, M., Venturini, M., Ciccarelli, L., Coati, F., Bortolami, O., & Verlato, G. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp287 · Cited by 125
Patient- versus physician-reporting of symptoms and health status in chronic myeloid leukemia
Efficace, F., Rosti, G., Aaronson, N. K., Cottone, F., Angelucci, E., Molica, S., Vignetti, M., Mandelli, F., & Baccarani, M. (2013) · Haematologica · doi:10.3324/haematol.2013.093724 · Cited by 123
Impact of oxaliplatin-induced neuropathy: a patient perspective
Bennett, B. K., Park, S. B., Lin, C. S.-Y., Friedlander, M. L., Kiernan, M. C., & Goldstein, D. (2012) · Supportive Care in Cancer · doi:10.1007/s00520-012-1428-5 · Cited by 115
Gravis, G., Marino, P., Joly, F., Oudard, S. M., Priou, F., Esterni, B., Latorzeff, I., Delva, R., Krakowski, I., Laguerre, B., et al. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2013.11.034 · Cited by 70
Franklin, H., Simonetti, G., Dubbelman, A. C., Huinink, W. W. T. B., Taal, B. G., Wigbout, G., Mandjes, I. A. M., Dalesio, O., & Aaronson, N. K. (1994) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a058760 · Cited by 70
Lung cancer in patients with HIV-infection
Vyzula, R., & Remick, S. C. (1996) · Lung Cancer · doi:10.1016/0169-5002(95)00596-x · Cited by 68
Neben-Wittich, M. A., Atherton, P. J., Schwartz, D. J., Sloan, J. A., Griffin, P. C., Deming, R. L., Anders, J. C., Loprinzi, C. L., Burger, K. N., Martenson, J. A., et al. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.05.065 · Cited by 67
Cella, D. F., Pulliam, J., Fuchs, H. J., Miller, C. B., Hurd, D. D., Wingard, J. R., Sonis, S. T., Martin, P. J., & Giles, F. J. (2003) · Cancer · doi:10.1002/cncr.11505 · Cited by 58
Patient-Reported Outcomes vs. Clinician Symptom Reporting During Chemoradiation for Rectal Cancer.
Flores, L., Bennett, A. V., Law, E. B., Hajj, C., Griffith, M. P., & Goodman, K. A. (2012) · PubMed · Cited by 57
Self-citationBasch, E. (2012) · Value in Health · doi:10.1016/j.jval.2012.03.1385 · Cited by 53
Self-citationBrabo, E. P., Paschoal, M. E. M., Biasoli, I., Nogueira, F. E., Gomes, M. C. B., Gomes, I. P., Martins, L. C. A., & Spector, N. (2006) · Quality of Life Research · doi:10.1007/s11136-006-0009-9 · Cited by 46
Do clinicians and patients agree regarding symptoms?
Kirchheiner, K., Nout, R. A., Lindegaard, J. C., Petrič, P., Limbergen, E. V., Jurgenliemk-Schulz, I. M., Haie-Méder, C., Pötter, R., & Dörr, W. (2012) · Strahlentherapie und Onkologie · doi:10.1007/s00066-012-0156-6 · Cited by 43
Cella, D. F., Huang, H. Q., Homesley, H. D., MONTAG, A. G., Salani, R., Geest, K. D., Lee, R., & Spirtos, N. M. (2010) · Gynecologic Oncology · doi:10.1016/j.ygyno.2010.08.022 · Cited by 38
Hirsh, V., Okamoto, I., Hon, J. K., Page, R. D., Orsini, J. M., Sakai, H., Zhang, H., Renschler, M. F., & Socinski, M. A. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000011 · Cited by 33
for the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR) and the Groupe d’Investigateurs Nationaux pour les Etudes des Cancers de l’Ovaire (GINECO), Greimel, E., Bjelic‐Radisic, V., Pfisterer, J., Hilpert, F., Daghofer, F., Pujade-Lauraine, É., & du Bois, A. (2010) · Supportive Care in Cancer · doi:10.1007/s00520-010-0969-8 · Cited by 31
Tom, A. K., Bennett, A. V., Rothenstein, D., Law, E. B., & Goodman, K. A. (2017) · Quality of Life Research · doi:10.1007/s11136-017-1700-8 · Cited by 31
Self-citationChristodoulou, M., McCloskey, P., Stones, N., Bayman, N., Burt, P. A., Chittalia, A., Harris, M., Lee, L. W., Pemberton, L. S., Sheikh, H., et al. (2014) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2014.07.008 · Cited by 29
Mandalà, M., Cremonesi, M., Rocca, A., Cazzaniga, M. E., Ferretti, G., Cosimo, S. D., Ghilardi, M., Cabiddu, M., & Barni, S. (2005) · Supportive Care in Cancer · doi:10.1007/s00520-004-0741-z · Cited by 22
Steinsvik, E. A. S., Fosså, S. D., Axcrona, K., Fransson, P., Widmark, A., & Dahl, A. A. (2010) · The Journal of Urology · doi:10.1016/j.juro.2010.04.009 · Cited by 16
Capturing Acute Toxicity Data During Lung Radiotherapy by Using a Patient-Reported Assessment Tool
Tang, B., Giuliani, M., Le, L. W., Higgins, J., Bezjak, A., Brade, A. M., Cho, J., Sun, A. Y., & Hope, A. J. (2012) · Clinical Lung Cancer · doi:10.1016/j.cllc.2012.06.003 · Cited by 9
Incidence and Dose-volume Analysis of Acute Bladder Toxicity following Pelvic Radiotherapy
Park, J., Kim, Y. S., Park, J., Ahn, H., Kim, C., Kim, M.-J., Kim, J. H., & Ahn, S. D. (2014) · Tumori Journal · doi:10.1177/030089161410000213 · Cited by 8
Cited by
Systemic treatment of hepatocellular carcinoma: An EASL position paper
Bruix, J., Chan, S. L., Galle, P. R., Rimassa, L., & Sangro, B. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.07.004 · Cited by 380
Bolliger, M., Kroehnert, J.-A., Molineus, F., Kandioler, D., Schindl, M., & Riss, P. (2018) · European Surgery · doi:10.1007/s10353-018-0551-z · Cited by 266
The increasing value of eHealth in the delivery of patient-centred cancer care
Penedo, F. J., Oswald, L. B., Kronenfeld, J. P., Garcia, S. F., Cella, D., & Yanez, B. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30021-8 · Cited by 252
Harnessing consumer smartphone and wearable sensors for clinical cancer research
Low, C. A. (2020) · npj Digital Medicine · doi:10.1038/s41746-020-00351-x · Cited by 120
Rocque, G. B., Dionne-Odom, J. N., Stover, A. M., Daniel, C. L., Azuero, A., Huang, C.-H. S., Ingram, S. A., Franks, J. A., Caston, N. E., Dent, D. A. N., et al. (2022) · BMC Health Services Research · doi:10.1186/s12913-022-07914-6 · Cited by 27
Self-citation
Metadata
- Authors
- Atkinson, T. M., Ryan, S. J., Bennett, A. V., Stover, A. M., Saracino, R. M., Rogak, L. J., Jewell, S. T., Matsoukas, K., Li, Y., & Basch, E.
- Venue
- Supportive Care in Cancer
- Published
- 2016-06-03
- Volume
- 24
- Issue
- 8
- Pages
- 3669-3676
- ISSN
- 0941-4355 (ISSN-L)
- 1433-7339
- OpenAlex
- W2413118791
- Cited by
- 370
- References
- 39
- FWCI
- 3.04
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.